Literature DB >> 34035698

Review of Abdominal Migraine in Children.

Demiana J Azmy1, Cary M Qualia2.   

Abstract

Abdominal migraine is a type of functional abdominal pain disorder that affects 0.2% to 4.1% of children. It consists of paroxysmal, recurrent, and acute abdominal pain attacks with associated symptoms, including pallor, nausea, vomiting, anorexia, headache, and photophobia. In between episodes, patients return to their baseline health. Abdominal migraine is a clinical diagnosis. Its diagnostic criteria are outlined under the Rome IV criteria and the International Classification of Headache Disorders III criteria. Hypothesized contributors to its pathophysiology include a combination of visceral hypersensitivity, gut-brain enteric nervous system alterations, and psychological factors. Treatment is focused on preventive measures and mostly includes nonpharmacologic approaches. Possible pharmacologic treatments include abortive medications used for migraine headaches such as analgesics and antiemetics. Abdominal migraine is likely underdiagnosed and is poorly understood. Individuals who have abdominal migraine report a lower quality of life, rendering it an important diagnosis. The aim of this article is to review the epidemiology, clinical presentation, pathophysiology, diagnosis, and treatment of abdominal migraine in children.
Copyright © 2020, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Abdominal migraine; Rome IV criteria; abdominal pain; children; functional gastrointestinal disorders

Year:  2020        PMID: 34035698      PMCID: PMC8132691     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  43 in total

Review 1.  Systematic review of treatments for recurrent abdominal pain.

Authors:  Joy A Weydert; Thomas M Ball; Melinda F Davis
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

Review 2.  Abdominal migraine: evidence for existence and treatment options.

Authors:  George Russell; Ishaq Abu-Arafeh; David N K Symon
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation.

Authors:  Nathalie Weltens; Julie Iven; Lukas Van Oudenhove; Michiko Kano
Journal:  Ann N Y Acad Sci       Date:  2018-09       Impact factor: 5.691

4.  Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation.

Authors:  C O Ladd; M J Owens; C B Nemeroff
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

5.  The prognosis of childhood abdominal migraine.

Authors:  F Dignan; I Abu-Arafeh; G Russell
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

Review 6.  Migraine.

Authors:  David W Dodick
Journal:  Lancet       Date:  2018-03-06       Impact factor: 79.321

7.  Association between functional gastrointestinal diseases and exposure to abuse in teenagers.

Authors:  Niranga Manjuri Devanarayana; Shaman Rajindrajith; Madushanka S Perera; Samudu W Nishanthanie; Amaranath Karunanayake; Marc A Benninga
Journal:  J Trop Pediatr       Date:  2014-07-23       Impact factor: 1.165

Review 8.  Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.

Authors:  A Huertas-Ceballos; S Logan; C Bennett; C Macarthur
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Abdominal migraine in children: association between gastric motility parameters and clinical characteristics.

Authors:  Niranga Manjuri Devanarayana; Shaman Rajindrajith; Marc A Benninga
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

10.  Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.

Authors:  Cristina Tassorelli; Licia Grazzi; Marina de Tommaso; Giulia Pierangeli; Paolo Martelletti; Innocenzo Rainero; Stefanie Dorlas; Pierangelo Geppetti; Anna Ambrosini; Paola Sarchielli; Eric Liebler; Piero Barbanti
Journal:  Neurology       Date:  2018-06-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.